Tronox Limited
Nov 8, 2017

Tronox Reports Third Quarter 2017 Financial Results

Third Quarter Highlights (1):
- Strong performance - strategically, financially and operationally
- Revenue of $435 million up 28 percent versus prior year
- GAAP diluted EPS from continuing operations of ($0.26); adjusted EPS from continuing operations of $0.08 (Non-GAAP)
- Income from continuing operations of $51 million; adjusted EBITDA of $123 million up 112 percent versus prior year (Non-GAAP)
- TiO2 income from operations of $75 million up more than four-fold and adjusted EBITDA of $136 million up 79 percent versus prior year; adjusted EBITDA margin of 31 percent; free cash flow of $120 million (2)
- All funds now assembled to complete the planned Cristal transaction; cash and cash equivalents of $1,058 million; total liquidity of $1,296 million(3); additional $650 million of restricted cash
Strategic Developments:
- Sale of Alkali Chemicals business for $1,325 million completed on September 1, 2017; Alkali no longer reported as a segment(1)
- Debt refinancing lowered cost of debt, extended maturities, increased liquidity and added pay down flexibility; completed on September 22, 2017
- Shareholder approval to issue 37.58 million Class A Shares to Cristal in connection with the acquisition of Cristal's TiO2 business received on October 2, 2017
- Secondary offering of 22.425 million Class A shares completed by Exxaro Resources Limited on October 10, 2017
- Cristal TiO2 acquisition integration planning proceeding on schedule
1) Continuing operations include TiO2 and Corporate; Alkali Chemicals reported as a discontinued business; all prior periods reclassified accordingly
2) Free cash flow equals cash flow provided by (used in) operating activities less capital expenditures (Non-GAAP)
3) Total liquidity includes cash on hand and availability under current revolvers

STAMFORD, Conn., Nov. 8, 2017 /PRNewswire/ -- Tronox Limited (NYSE:TROX) reported revenue of $435 million for the third quarter 2017, up 28 percent from $339 million in the year-ago quarter and up 3 percent from $421 million in the prior quarter.  Income from operations of $51 million compared to nil in the year-ago quarter and $31 million in the prior quarter.  Net loss from continuing operations attributable to Tronox Limited was $31 million, or ($0.26) per diluted share, compared to a net loss from continuing operations attributable to Tronox Limited of $60 million, or ($0.53) per diluted share in the year-ago quarter and net loss from continuing operations attributable to Tronox Limited of $19 million, or ($0.16) per diluted share in the prior quarter.  Loss from continuing operations attributable to Tronox Limited included Cristal acquisition-related expenses of $13 million and a loss on the extinguishment of debt of $28 million. Excluding acquisition expenses and the loss on the extinguishment of debt, adjusted net income from continuing operations attributable to Tronox Limited (Non-GAAP) was $10 million, or $0.08 per diluted share. Net loss from discontinued operations, net of tax, was $216 million or ($1.81) per diluted share, including a loss on the sale of Alkali Chemicals of $233 million.  Adjusted EBITDA of $123 million was 112 percent higher than the $58 million reported in the year-ago quarter and 24 percent higher than the $99 million reported in the prior quarter. 

The Board of Directors declared a quarterly dividend of $0.045 per share payable on December 1, 2017, to shareholders of record of the company's Class A and Class B ordinary shares at the close of business on November 20, 2017.

Peter Johnston, chief executive officer of Tronox, said: "The third quarter was a very successful one for us - strategically, financially and operationally.  Our TiO2 business continued to deliver strong results, posting revenue growth of 28 percent, adjusted EBITDA growth of 79 percent and free cash flow of $120 million. TiO2 adjusted EBITDA margin was 31 percent. The last time a 31 percent adjusted EBITDA margin was achieved was the third quarter of 2012, when TiO2 pigment selling prices were 33 percent higher.  This level of performance clearly reflects the benefits of our vertical integration with all our assets in full operation and the extraordinary work by our global TiO2 team to reduce costs through the successful implementation of their Operational Excellence program. 

"We also made great progress on our strategic developments", said Johnston.  "We completed the sale of Alkali Chemicals for $1.325 billion.  We refinanced a significant portion of our balance sheet that lowered our cost of debt, extended maturities, increased liquidity and provided additional pay-down flexibility.  All funds are now assembled to complete the planned Cristal transaction.  Shareholder approval was received to issue 37.58 million Class A Shares to Cristal in connection with the transaction.  A secondary offering of 22.425 million of our Class A shares was successfully completed by Exxaro Resources Limited.  Most importantly, our Cristal TiO2 acquisition integration planning continues to proceed on schedule so that we can from day one begin to realize the substantial value creation enabled by our combination.  We are confident that 2017 will be a year of strong performance and that 2018 will be a transformational one for Tronox." 

Third Quarter 2017

Tronox TiO2

TiO2 segment revenue of $435 million increased 28 percent compared to $339 million in the year-ago quarter, driven primarily by higher selling prices for pigment, zircon and pig iron.   Pigment sales of $317 million increased 22 percent compared to $260 million in the year-ago quarter, as sales volumes increased 1 percent and average selling prices increased 21 percent (20 percent on a local currency basis).  Pigment selling prices were higher in all regions.  Titanium feedstock and co-products sales of $108 million increased 69 percent from $64 million in the year-ago quarter, driven by higher selling prices for zircon, natural rutile and pig iron, as well as higher sales volumes for zircon, pig iron and CP titanium slag.  Zircon sales volumes increased 10 percent and selling prices increased 19 percent. Natural rutile sales volumes were 3 percent lower while selling prices increased 5 percent.  Pig iron sales volumes increased 148 percent and selling prices increased 33 percent.  CP titanium slag sales occurred in the third quarter, whereas there were no sales in the prior-year quarter.  Ilmenite sales volumes increased 77 percent while selling prices decreased 5 percent due to product mix. 

Compared sequentially, TiO2 segment revenue of $435 million increased 3 percent versus $421 million in the prior quarter, driven primarily by higher zircon and pig iron sales volumes and higher pigment and zircon selling prices.  Pigment sales of $317 million were 4 percent higher than sales of $306 million in the prior quarter, as sales volumes were 5 percent lower, reflecting a normal seasonally lighter third quarter, while selling prices increased 9 percent (7 percent on a local currency basis).  Selling prices were higher in all regions.  Titanium feedstock and co-products sales of $108 million increased 9 percent from $99 million in the second quarter.  Zircon sales volumes increased 23 percent, as a shipment made in the quarter moved from the second quarter, while selling prices increased 13 percent.  Natural rutile sales volumes were 27 percent lower, while selling prices were level to the prior quarter.  Pig iron sales volumes increased 39 percent and selling prices were 2 percent higher.  Sales volumes for CP titanium slag were 33 percent lower than the second quarter, when a larger shipment was made and selling prices decreased 5 percent.  Ilmenite sales volumes decreased 66 percent, also due to shipment timing, while selling prices improved 3 percent. 

TiO2 segment adjusted EBITDA of $136 million was 79 percent higher than $76 million in the year-ago quarter, driven primarily by higher selling prices for pigment and zircon and the benefit of higher production efficiency across our integrated operations.  Compared sequentially, segment adjusted EBITDA of $136 million improved by 11 percent, from $123 million in the prior quarter, driven by higher pigment selling prices, higher zircon sales volumes and selling prices, and the benefit of higher production efficiency across our integrated operations. TiO2 segment income from operations of $75 million increased from $17 million in the year-ago quarter and $61 million in the prior quarter.  TiO2 delivered free cash flow of $120 million in the third quarter, as cash provided by operating activities was $142 million and capital expenditures were $22 million.

Corporate

Corporate loss from operations was $24 million, compared to a loss from operations of $17 million in the year-ago quarter and a loss from operations of $30 million in the prior quarter.  The loss from operations in the third quarter included professional fees of $13 million related to the Cristal transaction, offset by $5 million of Alkali transactional expenses that were reclassified to discontinued operations.  Corporate adjusted EBITDA of ($13) million compared to ($18) million in the year-ago quarter and ($24) million in the prior quarter.  Corporate cash used in operations was $105 million and capital expenditures were $1 million.  The $105 million of cash use includes $50 million related to semi-annual bond interest payments, made in the first and third quarters each year, $21 million of transaction costs related to the sale of Alkali Chemicals, and $13 million of transaction costs related to the Cristal acquisition. 

Consolidated

Selling, general and administrative expenses were $55 million in the third quarter, compared to $47 million in the year-ago quarter and $63 million in the prior quarter. The selling, general and administrative expenses in the third quarter included the net $8 million of professional fees related to the Cristal and Alkali transactions described above.  Interest and debt expense of $47 million compares to $46 million in the year-ago quarter and $47 million in the prior quarter.  On September 30, 2017, gross consolidated debt was $3,140 million, and debt net of cash and cash equivalents was $2,082 million.  Liquidity was $1,296 million, cash and cash equivalents were $1,058 million, and we had an additional $650 million of restricted cash for the planned Cristal acquisition.  Capital expenditures were $23 million and depreciation, depletion and amortization expense was $45 million.

Webcast Conference Call

Tronox will conduct a conference call on Thursday, November 9, 2017, at 8:30 a.m. ET (New York).  The live call is open to the public via Internet broadcast and telephone.

Internet Broadcast:  http://www.tronox.com/
Dial-in telephone numbers:
U.S. / Canada: +1.877.831.3840
International: +1.253.237.1184
Conference ID: 98785994
Conference Call Presentation Slides will be used during the conference call and are available on our website at http://www.tronox.com/ 

Webcast Conference Call Replay: Available via the Internet and telephone beginning on Thursday, November 9, 2017 at 11:30 a.m. ET (New York), until 11:30 p.m. ET (New York), on Tuesday, November 14, 2017.

Internet Replay: www.tronox.com
Replay dial-in telephone numbers:
U.S. / Canada: +1.855.859.2056
International: +1.404.537.3406
Conference ID: 98785994

Upcoming Conferences

During the fourth quarter 2017, a member of management is scheduled to present at the following conferences:

  • Citi Basic Materials Conference, New York, November 28, 2017
  • Goldman Sachs Metals & Mining Conference, New York, November 29, 2017

Accompanying conference materials will be available at http://investor.tronox.com

About Tronox

Tronox Limited is a vertically integrated mining and inorganic chemical business. The Company mines and processes titanium ore, zircon and other minerals, and manufactures titanium dioxide pigments that add brightness and durability to paints, plastics, paper, and other everyday products. For more information, visit tronox.com.

Forward Looking Statements

Statements in this release that are not historical are forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are subject to known and unknown risks, uncertainties and assumptions about us, may include projections of our future financial performance based on our growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements. These and other risk factors are discussed in the company's filings with the Securities and Exchange Commission (SEC), including those under the heading entitled "Risk Factors" in our Form 10-Q for the period ended June 30, 2017 and our Annual Report on Form 10-K for the year ended December 31, 2016.

Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for our management to predict all risks and uncertainties, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Unless otherwise required by applicable laws, we undertake no obligation to update or revise any forward-looking statements, whether because of new information or future developments.

Use of Non-U.S. GAAP Financial Information

To provide investors and others with additional information regarding Tronox Limited's operating results, we have disclosed in this press release certain non-U.S. GAAP financial measures, including EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, Free Cash Flow and Adjusted net loss attributable to Tronox.  These non-U.S. GAAP financial measures are a supplement to and not a substitute for or superior to, the company's results presented in accordance with U.S. GAAP.  The non-U.S. GAAP financial measures presented by the company may be different from non-U.S. GAAP financial measures presented by other companies.  The non-U.S. GAAP financial measures are provided to enhance the user's overall understanding of the company's operating performance. Specifically, the company believes the non-U.S. GAAP information provides useful measures to investors regarding the company's financial performance by excluding certain costs and expenses that the company believes are not indicative of its core operating results.  The presentation of these non-U.S. GAAP financial measures is not meant to be considered in isolation or as a substitute for results or guidance prepared and presented in accordance with U.S. GAAP.  A reconciliation of the non-U.S. GAAP financial measures to U.S. GAAP results is included herein.

Management believes these non-U.S. GAAP financial measures:

  • Reflect Tronox Limited's ongoing business in a manner that allows for meaningful period-to-period comparison and analysis of trends in its business, as they exclude income and expense that are not reflective of ongoing operating results;
  • Provide useful information to investors and others in understanding and evaluating Tronox Limited's operating results and future prospects in the same manner as management and in comparing financial results across accounting periods;
  • Provide additional view of the operating performance of the company by adding interest expenses, taxes, depreciation, depletion and amortization to the net income.  Further adjustments due to gain (loss) on extinguishment of debt  and stock-based compensation charges attempt to exclude items that are either non-cash or unusual in nature;
  • Assist investors to assess the company's compliance with financial covenants under its debt instruments;
  • Adjusted EBITDA is one of the primary measures management uses for planning and budgeting processes and to monitor and evaluate financial and operating results. Adjusted EBITDA is not a recognized term under U.S. GAAP and does not purport to be an alternative to measures of our financial performance as determined in accordance with U.S. GAAP, such as net income (loss). Because other companies may calculate EBITDA and Adjusted EBITDA differently than Tronox, EBITDA may not be, and Adjusted EBITDA as presented in this release is not, comparable to similarly titled measures reported by other companies, and
  • We believe that the non-U.S. GAAP financial measure "Adjusted net loss attributable to Tronox Limited" and its presentation on a per share basis provide useful information about our operating results to investors and securities analysts. We also believe that excluding the effects of these items from operating results allows management and investors to compare more easily the financial performance of our underlying businesses from period to period.

Media Contact: Bud Grebey
Direct: +1.203.705.3721

Investor Contact: Brennen Arndt
Direct: +1.203.705.3722

TRONOX LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (U.S. GAAP)

(UNAUDITED)

(Millions of U.S. dollars, except share and per share data)




































Three Months Ended September 30


Nine Months Ended September 30






















2017


2016


2017


2016

Net sales


$     435


$     339


$  1,234


$     957

Cost of goods sold


329


291


971


877

Gross profit


106


48


263


80

Selling, general, and administrative expenses


(55)


(47)


(186)


(135)

Restructuring income (expense)


-


(1)


1


(2)

Income (loss) from operations


51


-


78


(57)

Interest and debt expense, net


(47)


(46)


(140)


(138)

Gain (loss) on extinguishment of debt


(28)


-


(28)


4

Other income (expense), net


12


(10)


5


(22)

Income (loss) from continuing operations before income taxes


(12)


(56)


(85)


(213)

Income tax provision


(13)


(6)


(10)


(25)

Net income (loss) from continuing operations


(25)


(62)


(95)


(238)

Income (loss) from discontinued operations, net of tax


(216)


23


(179)


55

Net income (loss)


(241)


(39)


(274)


(183)

Net income (loss) attributable to noncontrolling interest


6


(2)


11


(1)

Net income (loss) attributable to Tronox Limited


$    (247)


$      (37)


$    (285)


$    (182)















Net income (loss) per share, basic and diluted:









Continuing operations 


$   (0.26)


$   (0.53)


$   (0.89)


$   (2.04)

Discontinued operations


$   (1.81)


$    0.20


$   (1.51)


$    0.47

Net income (loss) per share, basic and diluted


$   (2.07)


$   (0.33)


$   (2.40)


$   (1.57)















Weighted average shares outstanding, basic and diluted (in thousands)


119,405


116,219


118,908


116,108















Other Operating Data:










Capital expenditures


$        23


$        24


$        63


$        59


Depreciation, depletion and amortization expense


$        45


$        45


$     136


$     131

 

TRONOX LIMITED

RECONCILIATION OF NON-U.S. GAAP FINANCIAL MEASURES

(UNAUDITED)

(Millions of U.S. dollars, except share and per share data)


RECONCILIATION OF NET INCOME (LOSS)

ATTRIBUTABLE TO TRONOX LIMITED  (U.S. GAAP)

TO ADJUSTED NET INCOME (LOSS) FROM CONTINUING OPERATIONS

ATTRIBUTABLE TO TRONOX LIMITED (NON-U.S. GAAP)





















Three Months Ended September 30


Nine Months Ended September 30



2017


2016


2017


2016










Net income (loss) attributable to Tronox Limited (U.S. GAAP)


$    (247)


$      (37)


$    (285)


$    (182)

Income (loss) from discontinued operations, net of tax (U.S. GAAP)


(216)


23


(179)


55

Net income (loss) from continuing operations attributable to Tronox Limited (U.S. GAAP)


$      (31)


$      (60)


$    (106)


$    (237)

Acquisition related matters (a)


13


-


33


-

Restructuring (income) expense (b)


-


1


(1)


2

(Gain) loss on extinguishment of debt (c)


28


-


28


(4)

Adjusted net income (loss) from continuing operations attributable to Tronox Limited (non-U.S. GAAP) (d)


$        10


$      (59)


$      (46)


$    (239)










Basic and diluted net income (loss) per share from continuing operations (U.S. GAAP)


$   (0.26)


$   (0.53)


$   (0.89)


$   (2.04)










Acquisition related expense, per share


0.11


-


0.28


-

Restructuring (income) expense, per share


-


0.02


(0.02)


0.02

(Gain) loss on extinguishment of debt, per share


0.23


-


0.24


(0.04)

Diluted adjusted net income (loss) from continuing operations per share attributable to Tronox Limited (non-U.S. GAAP)


$    0.08


$   (0.51)


$   (0.39)


$   (2.06)










Weighted average shares outstanding, diluted (in thousands)


119,405


116,219


118,908


116,108


(a)   Represents transaction costs associated with the Cristal Transaction which were recorded in "Selling, general and administrative expenses" in the unaudited Condensed Consolidated Statements of Operations during the three and nine months ended September 30, 2017.

(b)   Represents severance costs associated with the shutdown of our sodium chlorate plant and other global restructuring efforts, which was recorded in "Restructuring (income) expense" in the unaudited Condensed Consolidated Statements of Operations.

(c)   Represents a $28 million loss which includes a $22 million loss associated with the redemption of the outstanding balance of the Senior Notes due 2020, $1 million of unamortized original debt issuance costs from the repayment of the UBS Revolver, and $5 million of debt issuance costs from the refinancing activities associated with the term loans. During 2016, the $4 million gain was associated with the repurchase of $20 million face value of our Senior Notes due 2020 and Senior Notes 2022.  These amounts were recorded in "Gain (loss) on extinguishment of debt" in the unaudited Condensed Consolidated Statements of Operations.

(d)   No income tax impact given full valuation allowance except for South Africa restructuring related costs of less than $1 million

 

TRONOX LIMITED

SEGMENT INFORMATION

(UNAUDITED)

(Millions of U.S. dollars)





















Three Months Ended September 30


Nine Months Ended September 30



2017


2016


2017


2016

Net sales (TiO2)


$  435


$ 339


$ 1,234


$  957










TiO2 segment


$     75


$   17


$    168


$   (12)

Corporate


(24)


(17)


(90)


(45)

Income (loss) from operations


51


-


78


(57)

Interest and debt expense, net


(47)


(46)


(140)


(138)

Gain (loss) on extinguishment of debt


(28)


-


(28)


4

Other income (expense), net


12


(10)


5


(22)

Income (loss) from continuing operations before income taxes


(12)


(56)


(85)


(213)

Income tax provision


(13)


(6)


(10)


(25)

Net income (loss) from continuing operations


(25)


(62)


(95)


(238)

Income (loss) from discontinued operations, net of tax


(216)


23


(179)


55

Net income (loss)


(241)


(39)


(274)


(183)

Net income (loss) attributable to noncontrolling interest


6


(2)


11


(1)

Net income (loss) attributable to Tronox Limited


$ (247)


$  (37)


$   (285)


$ (182)

 

TRONOX LIMITED

CONDENSED CONSOLIDATED BALANCE SHEETS

 (UNAUDITED)

(Millions of U.S. dollars, except share and per share data)
















September 30,


December 31




2017


2016

ASSETS




Current Assets





Cash and cash equivalents

$             1,058


$              248


Restricted cash 

653


3


Accounts receivable, net of allowance for doubtful accounts

309


278


Inventories, net

459


499


Prepaid and other assets

44


28


Income taxes receivable

1


11


Total assets of discontinued operations

-


1,671



Total current assets

2,524


2,738







Noncurrent Assets





Property, plant and equipment, net

1,069


1,092


Mineral leaseholds, net

859


877


Intangible assets, net

203


223


Inventories, net

14


14


Other long-term assets

22


20



Total assets

$              4,691


$           4,964







LIABILITIES AND EQUITY




Current Liabilities





Accounts payable

$                 155


$              136


Accrued liabilities

131


150


Short-term debt

-


150


Long-term debt due within one year

11


16


Income taxes payable

2


1


Total liabilities of discontinued operations

-


111



Total current liabilities

299


564







Noncurrent Liabilities





Long-term debt, net

3,129


2,888


Pension and postretirement healthcare benefits

100


114


Asset retirement obligations

78


73


Long-term deferred tax liabilities

161


151


Other long-term liabilities

18


21



Total liabilities 

3,785


3,811







Commitments and Contingencies




Shareholders' Equity





Tronox Limited Class A ordinary shares, par value $0.01 — 68,767,566  shares issued and 68,591,094 shares outstanding at September 30, 2017 and 65,998,306  shares issued and 65,165,672  shares outstanding at December 31, 2016

1


1


Tronox Limited Class B ordinary shares, par value $0.01 — 51,154,280 shares issued and outstanding at September 30, 2017 and December 31, 2016.

-


-


Capital in excess of par value 

1,542


1,524


Accumulated deficit

(321)


(19)


Accumulated other comprehensive loss

(474)


(497)



Total Tronox Limited shareholders' equity

748


1,009


Noncontrolling interest

158


144



Total equity

906


1,153



Total liabilities and equity 

$             4,691


$           4,964

 

TRONOX LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 (UNAUDITED)

(Millions of U.S. dollars)










Nine Months Ended September 30


2017


2016

Cash Flows from Operating Activities:




Net income (loss)

$              (274)


$              (183)

Income (loss) from discontinued operations, net of tax

(179)


55

Net income (loss) from continuing operations

$                (95)


$              (238)

Adjustments to reconcile net loss from continuing operations to net cash provided by operating activities, continuing operations:




Depreciation, depletion and amortization 

136


131

Deferred income taxes 

8


(5)

Share-based compensation expense

26


18

Amortization of deferred debt issuance costs and discount on debt

9


8

Pension and postretirement healthcare benefit expense

2


-

(Gain) loss on extinguishment of debt

28


(4)

Other, net

22


35

Contributions to employee pension and postretirement plans

(18)


(15)

Changes in assets and liabilities:




(Increase) decrease in accounts receivable, net

(29)


(3)

(Increase) decrease in inventories, net

48


94

(Increase) decrease in prepaid and other assets

(16)


(3)

Increase (decrease) in accounts payable and accrued liabilities

(27)


(33)

Increase (decrease) in income taxes payable

-


28

Cash provided by operating activities, continuing operations

94


13





Cash Flows from Investing Activities:




Capital expenditures 

(63)


(59)

Debt proceeds restricted for Cristal acquisition

(650)


-

Proceeds from the sale of business

1,325


-

Proceeds from the sale of assets

-


1

Cash provided by (used in) investing activities, continuing operations

612


(58)





Cash Flows from Financing Activities:




Repayments of long-term debt

(2,342)


(27)

Repayments of short-term debt

(150)


-

Proceeds from long-term debt

2,589


-

Debt issuance costs

(36)


-

Call premium paid

(14)


-

Proceeds from options and warrants

1


-

Dividends paid

(17)


(40)

Restricted stock and performance-based shares settled in cash for taxes

(11)


(1)

Cash provided by (used in) financing activities, continuing operations

20


(68)





Discontinued Operations:




Cash provided by operating activities

107


112

Cash used in investing activities

(25)


(29)

Net cash flows provided by discontinued operations

82


83





Effects of exchange rate changes on cash and cash equivalents 

2


3

Net increase (decrease) in cash and cash equivalents 

810


(27)

Cash and cash equivalents at beginning of period 

248


229

Cash and cash equivalents at end of period, continuing operations 

$             1,058


$              202

 

TRONOX LIMITED

CONDENSED STATEMENT OF FREE CASH FLOWS (NON-U.S. GAAP)

(UNAUDITED)

(Millions of U.S. dollars)


























Three Months Ended September 30, 2017


Nine Months Ended September 30, 2017














TiO2


Corporate


Consolidated


TiO2


Corporate


Consolidated













Income (loss) from operations (U.S. GAAP)

$   75


$         (24)


$                51


$ 168


$         (90)


$                78

Depreciation, depletion and amortization expense

44


1


45


132


4


136

Other

17


10


27


44


27


71

Adjusted EBITDA (non-U.S. GAAP)

$ 136


$         (13)


$              123


$ 344


$         (59)


$              285













Adjusted EBITDA (non-U.S. GAAP)

$ 136


$         (13)


$              123


$ 344


$         (59)


$              285

Interest paid, net of capitalized interest and interest income 

-


(73)


(73)


-


(157)


(157)

Income tax provision

-


(13)


(13)


-


(10)


(10)

Transaction costs

-


(13)


(13)


-


(33)


(33)

Contributions to employee pension and postretirement plans

(9)


-


(9)


(18)


-


(18)

Deferred income taxes

-


6


6


-


8


8

Other

3


40


43


3


40


43













Changes in assets and liabilities












(Increase) decrease in accounts receivable, net

6


-


6


(29)


-


(29)

(Increase) decrease in inventories, net

11


-


11


48


-


48

(Increase) decrease in prepaid and other assets

(2)


(4)


(6)


(12)


(4)


(16)

Increase (decrease) in accounts payable and accrued liabilities

(3)


(34)


(37)


3


(30)


(27)

Increase (decrease) in income taxes payable

-


(1)


(1)


-


-


-

Subtotal

12


(39)


(27)


10


(34)


(24)













Cash provided by (used in) operating activities, continuing operations

142


(105)


37


339


(245)


94













Capital expenditures

(22)


(1)


(23)


(61)


(2)


(63)

 Free cash flow (non-U.S. GAAP) 

$ 120


$      (106)


$                14


$ 278


$      (247)


$                31

 

TRONOX LIMITED

RECONCILIATION OF NET INCOME (LOSS) TO EBITDA AND ADJUSTED EBITDA (NON-U.S. GAAP)

(UNAUDITED)

(Millions of U.S. dollars)





















Three Months Ended September 30


Nine Months Ended September 30



2017


2016


2017


2016










Net income (loss) (U.S. GAAP)

$(241)


$(39)


$(274)


$(183)

Income (loss) from discontinued operations, net of tax (U.S. GAAP)

(216)


23


(179)


55

Net income (loss) from continuing operations (U.S. GAAP)

(25)


(62)


(95)


(238)


Interest and debt expense, net

47


46


140


138


Interest income

(3)


-


(5)


(2)


Income tax provision

13


6


10


25


Depreciation, depletion and amortization expense

45


45


136


131

EBITDA (non-U.S. GAAP)

77


35


186


54


Share-based compensation (a)

5


8


26


18


Transaction costs (b)

13


-


33


-


Restructuring (income) expense (c)

-


1


(1)


2


(Gain) loss on extinguishment of debt (d)

28


-


28


(4)


Foreign currency remeasurement (e)

(5)


14


1


32


Other items (f)

5


-


12


4

Adjusted EBITDA (non-U.S. GAAP) (g)

$  123


$  58


$  285


$  106



(a)

Represents non-cash share-based compensation. 

(b)

Represents transaction costs associated with the Cristal Transaction which were recorded in "Selling, general and administrative expenses" in the unaudited Condensed Consolidated Statements of Operations. 

(c)

Represents severance and other costs associated with the shutdown of our sodium chlorate plant, and other global restructuring efforts which was recorded in "Restructuring income (expense)" in the unaudited Condensed Consolidated Statements of Operations. 

(d)

Represents a $28 million loss which includes a $22 million loss associated with the redemption of the outstanding balance of the Senior Notes due 2020, $1 million of unamortized original debt issuance costs from the repayment of the UBS Revolver, and $5 million of debt issuance costs from the refinancing activities associated with the term loans. During 2016, the $4 million gain was associated with the repurchase of $20 million face value of our Senior Notes due 2020 and Senior Notes 2022.  These amounts were recorded in "Gain (loss) on extinguishment of debt" in the unaudited Condensed Consolidated Statements of Operations.

(e)

Represents foreign currency remeasurement which is included in "Other income (expense), net" in the unaudited Condensed Consolidated Statements of Operations.

(f)

Includes noncash pension and postretirement costs, severance expense, accretion expense, insurance settlement gain and other items included in "Selling, general and administrative expenses" and "Cost of goods sold" in the unaudited Condensed Consolidated Statements of Operations. 

(g)

No income tax impact given full valuation allowance except for South Africa related restructuring costs.

The following table reconciles income (loss) from operations, the comparable measure for segment reporting under U.S. GAAP, to Adjusted EBITDA by segment for the periods presented:


Three Months Ended September 30


Nine Months Ended September 30


2017


2016


2017


2016









TiO2 segment

$    75


$  17


$  168


$   (12)

Corporate

(24)


(17)


(90)


(45)

Income (loss) from operations (U.S. GAAP)

51


-


78


(57)









TiO2 segment

44


44


132


127

Corporate

1


1


4


4

Depreciation, depletion and amortization expense

45


45


136


131









TiO2 segment

17


15


44


41

Corporate

10


(2)


27


(9)

Other

27


13


71


32









TiO2 segment

136


76


344


156

Corporate

(13)


(18)


(59)


(50)

Adjusted EBITDA (non-U.S. GAAP)

$  123


$  58


$  285


$  106

 

TRONOX LIMITED 

REVISION OF PREVIOUSLY ISSUED INTERIM UNAUDITED CONDENSED 

CONSOLIDATED FINANCIAL STATEMENTS

(Millions of U.S. dollars)















Unaudited Condensed Consolidated Statement of Operations


















Three Months Ended September 30, 2016


Nine Months Ended September 30, 2016




As
Reported (1)


Adjustment


Revised


As
Reported (1)


Adjustment


Revised


Net sales


$       339


$              -


$       339


$       957


$              -


$       957


Cost of goods sold


290


1


291


877


-


877


Gross profit


49


(1)


48


80


-


80


Selling, general and administrative expenses


(47)


-


(47)


(131)


(4)


(135)


Income (loss) from operations


1


(1)


-


(53)


(4)


(57)


Other income (expense), net


(13)


3


(10)


(22)


-


(22)


Income (loss) from continuing operations before income taxes


(58)


2


(56)


(209)


(4)


(213)


Net income (loss) from continuing operations


(64)


2


(62)


(235)


(3)


(238)


Income (loss) from discontinued operations, net of tax


22


1


23


53


2


55


Net income (loss) attributable to Tronox Limited 


(40)


3


(37)


(181)


(1)


(182)


Net income (loss) per share from continuing operations, basic and diluted


(0.54)


0.01


(0.53)


(2.02)


(0.02)


(2.04)


Net income (loss) per share from discontinued operations, basic and diluted


0.19


0.01


0.20


0.46


0.01


0.47


Weighted average shares outstanding, basic and diluted (in thousands)


116,219


116,219


116,219


116,108


116,108


116,108

 

Unaudited Condensed Consolidated Balance Sheet












December 31, 2016




As
Reported (1)


Adjustment


Revised


Current assets of continuing operations


$   1,067


$              -


$   1,067


Total assets of discontinued operations


1,668


3


1,671


Total current assets


2,735


3


2,738


Total assets


4,961


3


4,964


Accrued liabilities


138


11


149


Current liabilities of continuing operations 


443


10


453


Total liabilities of discontinued operations


110


1


111


Total current liabilities


553


11


564


Total liabilities


3,800


11


3,811


Accumulated deficit


(13)


(6)


(19)


Accumulated other comprehensive loss


(495)


(2)


(497)


Total Tronox Limited shareholders' equity


1,017


(8)


1,009


Total equity


1,161


(8)


1,153


Total liabilities and equity


4,961


3


4,964


(1)Amounts reflect the results of Alkali as discontinued operations. 


Unaudited Condensed Consolidated Statement of Cash Flows


   There was no net impact to operating, investing and financing cash flows from the revisions for continuing operations for the nine months ended September 30, 2016.

 

View original content:http://www.prnewswire.com/news-releases/tronox-reports-third-quarter-2017-financial-results-300552451.html

SOURCE Tronox Limited

News Provided by Acquire Media